Barry Reisberg, MD

  • Specialties: Adult Psychiatry, Geriatric Psychiatry
  • Language: English
  • Phone: 212-263-8550

About Me

Conditions and Treatments

Alzheimer's disease, memory loss, cognitive disorder, dementia, depressive disorder, bipolar disorder, memory disorders, anxiety disorder, mood disorder, psychological testing, cerebrovascular disorder
Show More Conditions

Credentials

Positions
  • Professor, Department of Psychiatry
  • Clinical Dir Aging & Dementia Rsch Ctr
  • Director of the Zachary and Elizabeth M. Fisher Alzheimer Disease Education and Research program
Board Certifications
  • American Board of Psychiatry & Neurology - Psychiatry, 1976
Education and Training
  • Residency, Metropolitan Hospital, Psychiatry, 1975
  • MD from New York University, 1972
Departments

Locations and Appointments

Dept. of Psychiatry

560 First Avenue
New York, NY 10016

Contact

Phone: 212-263-8550

Welcome back!

As a returning patient for this doctor, please schedule an appointment using your MyChart at NYU Langone account.

Learn more about MyChart at NYU Langone.

Research My Research

Barry Reisberg, M.D. has directed research over the past three decades which has significantly advanced current understanding and treatment of Alzheimer's disease (AD). He was the first to describe many of the most important symptoms of AD and the characteristic clinical course of the disease. His staging tools are presently governmentally mandated measures throughout the U.S., in some Canadian and European provinces, and recommended in Japan. Dr. Reisberg's work has been instrumental in the worldwide development of all three major current pharmacological treatment modalities for AD, i.e., glutamatergic antagonist treatment (memantine), treatment for behavioral disturbances in dementia (e.g., risperidone), and in the development and approval of cholinesterase inhibitor treatment (e.g., rivastigmine for mild to moderate dementia and donepezil for severe dementia). For example, Dr. Reisberg was the principal designer and Principal Investigator of the pivotal trial, published in the New England Journal of Medicine, which resulted in the US and European Union approval of the first treatment for advanced AD, memantine. Dr. Reisberg and his associates developed the concepts behind and coined the terminology, "mild cognitive impairment," a now universally recognized entity. His descriptions of an even earlier clinically manifest stage - "subjective cognitive impairment," are increasingly being recognized as the earliest manifestations of AD in seemingly normal persons. At the other end of the severity spectrum, Dr. Reisberg's staging procedures have been used in the pivotal worldwide trials of all currently approved medications for advanced AD. Dr. Reisberg's description of the retrogenic neurodevelopmental process in AD and related dementias is also advancing a new science of AD management and providing new insights into AD etiopathogenesis. Dr. Reisberg has been the recipient of numerous grants and awards for his pioneering research including a Lifetime Achievement Award for Research in Alzheimer's disease from the major worldwide organizations in the field. Dr. Reisberg is the Director of the Clinical Core of the US National Institute on Aging (NIH) funded Alzheimer's Disease Center of the New York University School of Medicine and Clinical Director of the Aging and Dementia Research Center of the NYU School of Medicine. He serves as Professor of Psychiatry at NYU. Dr. Reisberg is also Director of the Zachary and Elizabeth M. Fisher Alzheimer's Disease Education and Resources Program at the NYU School of Medicine. Additionally, Dr. Reisberg is an Adjunct Professor at the McGill University Faculty of Medicine in Montreal, Canada.

Publications

  • Assessment of the genetic variance of late-onset Alzheimer's disease

    Adams, P M; Albert, M S; Albin, R L; Apostolova, L G; Arnold, S E; Asthana, S; Atwood, C S; Baldwin, C T; Barber, R C; Barmada, M M; Barnes, L L; Barral, S; Beach, T G; Becker, J T; Beecham, G W; Beekly, D; Bennett, D A; Bigio, E H; Bird, T D; Blacker, D; Boeve, B F; Bowen, J D; Boxer, A; Burke, J R; Adams, P M; Albert, M S; Albin, R L; Apostolova, L G; Arnold, S E; Asthana, S; Atwood, C S; Baldwin, C T; Barber, R C; Barmada, M M; Barnes, L L; Barral, S; Beach, T G; Becker, J T; Beecham, G W; Beekly, D; Bennett, D A; Bigio, E H; Bird, T D; Blacker, D; Boeve, B F; Bowen, J D; Boxer, A; Burke, J R; Burns, J M; Buxbaum, J D; Cairns, N J; Cantwell, L B; Cao, C; Carlson, C S; Carlsson, C M; Carney, R M; Carrasquillo, M M; Carroll, S L; Chui, H C; Clark, D G; Corneveaux, J; David, C H; Crocco, E A; Cruchaga, C; De, Jager P L; DeCarli, C; Yesim, Demirci F; Dick, M; Dickson, D W; Doody, R S; Duara, R; Ertekin-Taner, N; Evans, D A; Faber, K M; Fairchild, T J; Fallon, K B; Fardo, D W; Farlow, M R; Ferris, S; Foroud, T M; Frosch, M P; Galasko, D R; Gearing, M; Geschwind, D H; Ghetti, B; Gilbert, J R; Goate, A M; Graff-Radford, N R; Green, R C; Growdon, J H; Hakonarson, H; Hamilton, R L; Hamilton-Nelson, K L; Hardy, J; Harrell, L E; Honig, L S; Huebinger, R M; Huentelman, M J; Hulette, C M; Hyman, B T; Jarvik, G P; Jicha, G A; Jin, L -W; Jun, G; Kamboh, M I; Karydas, A; Katz, M J; Kaye, J A; Kim, R; Kowall, N W; Kramer, J H; Kukull, W A; Kunkle, B W; LaFerla, F M; Lah, J J; Larson, E B; Leverenz, J B; Levey, A I; Li, G; Lieberman, A P; Lin, C -F; Lipton, R B; Lopez, O L; Lunetta, K L; Lyketsos, C G; Mack, W J; Marson, D C; Martin, E R; Martiniuk, F; Mash, D C; Masliah, E; McCormick, W C; McCurry, S M; McDavid, A N; McKee, A C; Mesulam, M; Miller, B L; Miller, C A; Miller, J W; Montine, T J; Morris, J C; Mukherjee, S; Murrell, J R; Myers, A J; Naj, A C; O'Bryant, S; Olichney, J M; Pankratz, V S; Parisi, J E; Partch, A; Paulson, H L; Perry, W; Peskind, E; Petersen, R C; Pierce, A; Poon, W W; Potter, H; Quinn, J F; Raj, A; Raskind, M; Reiman, E M; Reisberg, B; Reisch, J S; Reitz, C; Ringman, J M; Roberson, E D; Rogaeva, E; Rosen, H J; Rosenberg, R N; Royall, D R; Sager, M A; Sano, M; Saykin, A J; Schneider, J A; Schneider, L S; Seeley, W W; Smith, A G; Sonnen, J A; Spina, S; St, George-Hyslop P; Stern, R A; Swerdlow, R H; Tanzi, R E; Thornton-Wells, T A; Trojanowski, J Q; Troncoso, J C; Tsuang, D W; Valladares, O; Van, Deerlin V M; Van, Eldik L J; Vardarajan, B N; Vinters, H V; Vonsattel, J P; Wang, L -S; Weintraub, S; Welsh-Bohmer, K A; Wendland, J R; Wilhelmsen, K C; Williamson, J; Wingo, T S; Winslow, A R; Wishnek, S; Woltjer, R L; Wright, C B; Wu, C -K; Younkin, S G; Yu, C -E; Yu, L; Ridge, P G; Hoyt, K B; Boehme, K; Crane, P K; Haines, J L; Mayeux, R; Farrer, L A; Pericak-Vance, M A; Schellenberg, G D; Kauwe, J S K
    Neurobiology of aging. 2016 May 01, 2016. 41 (pp): 200.e13-200.e20
    Show More Authors

  • Implementation of subjective cognitive decline criteria in research studies

    Molinuevo, Jose L; Rabin, Laura A; Amariglio, Rebecca; Buckley, Rachel; Dubois, Bruno; Ellis, Kathryn A; Ewers, Michael; Hampel, Harald; Kloppel, Stefan; Rami, Lorena; Reisberg, Barry; Saykin, Andrew J; Sikkes, Sietske; Smart, Colette M; Snitz, Beth E; Sperling, Reisa; van der Flier, Wiesje M; Wagner, Molinuevo, Jose L; Rabin, Laura A; Amariglio, Rebecca; Buckley, Rachel; Dubois, Bruno; Ellis, Kathryn A; Ewers, Michael; Hampel, Harald; Kloppel, Stefan; Rami, Lorena; Reisberg, Barry; Saykin, Andrew J; Sikkes, Sietske; Smart, Colette M; Snitz, Beth E; Sperling, Reisa; van der Flier, Wiesje M; Wagner, Michael; Jessen, Frank
    Alzheimer's & dementia. 2016 Nov 5. ?-?
    Show More Authors

  • Ecopsychosocial Interventions in Cognitive Decline and Dementia: A New Terminology and a New Paradigm

    Zeisel, John; Reisberg, Barry; Whitehouse, Peter; Woods, Robert; Verheul, Ad Zeisel, John; Reisberg, Barry; Whitehouse, Peter; Woods, Robert; Verheul, Ad
    American journal of Alzheimer's disease & other dementias. 2016 Jun 9. 31 (6): 502-507

Read All Publications (257)